Mirum Pharmaceuticals MIRM Cash Flow Statement (2018-2026)

NASDAQ MIRM
$83.88 -1.19 (-1.40%)
As of: Oct 21, 2026 · 1:50 PM EDT
Reported Financials

Mirum Pharmaceuticals Quarterly Cash Flow Statement

Periods 31 quarters
Latest Jun 2026

Mirum Pharmaceuticals reported cash from operations of -$44.25M and free cash flow of -$44.27M for the quarter ended Jun 2026, down 467.5% year over year. This cash flow statement covers 31 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-47.11M57.55M-36.61M-26.92M-35.71M-36.43M-30.13M-74.04M-23.59M-35.66M-25.28M-24.64M-14.24M-23.79M-14.68M-5.86M2.91M-5.73M-790.16M-67.23M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.31M0.41M0.40M0.41M0.41M0.42M0.42M0.43M0.43M0.44M0.44M0.45M0.66M
Depreciation & Amortization (CF)Dep. & Amort.
0.08M0.34M0.34M0.60M1.10M1.20M1.34M1.34M2.66M5.49M5.66M5.85M6.06M6.06M6.05M6.06M6.06M6.07M6.87M6.94M
Share-based CompensationStock Comp.
7.42M5.56M6.56M6.64M6.91M6.90M8.56M8.36M8.39M9.72M11.45M11.84M11.91M13.25M15.80M18.47M18.13M19.03M36.20M30.57M
Other non-cash itemsOther Non-Cash
0.09M0.10M0.10M-3.38M-0.15M49.08M-1.40M3.15M-1.22M-0.40M1.00M-0.15M-0.67M-0.60M-0.51M0.27M1.37M0.90M
Change in Working Capital
Change in ReceivablesChange Receivables
4.61M6.12M2.35M7.66M0.67M10.67M12.51M20.13M-12.97M5.43M8.10M10.86M16.83M9.07M3.15M19.01M12.89M13.74M
Change in InventoryChange Inventory
0.50M0.07M1.18M2.80M-0.60M0.78M0.99M0.44M-1.23M0.96M1.09M0.90M0.21M2.67M2.34M1.16M2.28M1.92M-0.40M
Change in Accured ExpensesChange Accured Exp.
3.78M9.02M-8.07M8.89M6.83M-0.01M-1.21M9.18M10.29M12.53M11.28M6.94M12.75M9.34M11.74M10.58M24.35M3.44M57.24M-19.06M
Change in Other Operating AssetsOther Assets Change
2.56M1.91M0.88M-2.11M3.31M1.71M-0.25M0.80M2.71M0.84M-0.93M-1.33M4.88M-0.27M3.12M5.34M7.32M-4.35M11.43M6.92M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.16M-0.16M-0.17M-0.18M-0.18M-0.18M-0.22M-0.22M-0.27M-0.23M-0.27M-0.19M-0.11M-0.21M-0.41M-0.40M-0.58M-0.51M-0.58M-0.63M
Other Working Capital ChangesOther WC Changes
-2.72M-2.08M-1.05M1.93M-3.50M-1.89M0.03M-1.02M-2.98M-1.07M0.66M1.14M-4.98M0.06M-3.53M-5.73M-7.90M3.84M-12.01M-7.55M
Cash from OperationsCash from Ops.
-34.20M-33.15M-39.67M-20.17M-26.03M-34.27M-18.77M-17.33M-18.22M-16.62M15.21M-3.80M3.98M-5.07M-1.96M12.04M39.68M6.07M-228.76M-44.25M
Investing Activities
Capital ExpendituresCapex
0.02M0.00M0.02M0.02M0.24M0.04M0.07M0.01M0.78M0.18M0.02M0.04M0.13M0.19M0.60M0.66M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.02M0.00M-0.02M-0.02M-0.24M-0.04M-0.07M-0.01M-0.78M-0.18M-0.02M-0.04M-0.13M-0.19M-0.60M-0.66M-0.02M
Change in IntangiblesChange Intangibless
15.00M5.00M10.00M10.00M10.00M25.00M
Purchase of InvestmentsInvestments Purchased
49.72M18.97M14.81M117.51M22.44M4.89M61.94M15.61M11.48M33.53M31.54M20.86M11.50M34.80M160.82M
Sale and Maturity of InvestmentsInvestments Sold
47.50M38.00M36.50M38.80M38.00M27.00M64.50M55.50M30.00M3.00M7.75M12.14M17.43M25.06M18.82M13.11M33.89M25.85M
Cash from Investing ActivitiesCash from Investing
-2.24M108.02M36.50M23.97M-79.53M26.76M27.02M50.55M-182.76M-2.00M-0.01M-72.72M-18.04M0.64M-16.13M-6.60M-2.23M1.01M-11.57M-159.99M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
0.35M0.74M18.86M6.35M87.74M1.70M15.87M2.10M207.13M2.06M1.21M7.29M3.86M5.34M6.36M8.69M16.10M9.00M270.08M13.37M
Net Shares Issued and RepurchasedNet Shares Issued
0.35M0.74M18.86M6.35M87.74M1.70M15.87M2.10M207.13M2.06M1.21M7.29M3.86M5.34M6.36M8.69M16.10M9.00M270.08M13.37M
Net Equity Issued and RepurchasedNet Equity Issued
0.35M0.74M18.86M6.35M87.74M1.70M15.87M2.10M207.13M2.06M1.21M7.29M3.86M5.34M6.36M8.69M16.10M9.00M270.08M13.37M
Other financing activitiesOther financing
-0.12M-0.76M-1.10M-1.67M-2.03M-2.88M-192.69M-0.28M
Cash from Financing ActivitiesCash from Financing
0.35M0.62M18.10M5.25M86.07M-0.33M12.99M114.71M207.13M1.78M1.21M7.29M3.86M5.34M6.36M8.69M16.10M9.00M270.08M211.44M
Additional items
Exchange Rate EffectFX Effect
0.01M0.00M-0.05M-0.02M0.09M0.19M-0.11M-0.32M0.11M0.11M-0.12M0.09M-1.38M1.06M2.23M0.35M-0.41M-1.27M-1.37M
Change in Cash
-36.09M75.50M14.93M9.00M-19.51M-7.76M21.42M147.81M5.83M-16.73M16.52M-69.35M-10.10M-0.47M-10.68M16.36M53.90M15.66M28.48M5.82M
Ending Cash Balance
55.84M131.34M128.00M149.42M297.23M303.06M286.33M302.84M233.50M223.39M222.93M212.25M228.60M282.50M298.17M326.64M332.46M
Free Cash FlowFCF
-34.22M-33.15M-39.67M-20.19M-26.04M-34.51M-18.82M-17.40M-18.22M-16.62M15.20M-4.58M3.80M-5.09M-2.00M11.91M39.49M5.47M-229.43M-44.28M
Net Cash FlowNCF
-36.09M75.49M14.94M9.05M-19.49M-7.84M21.23M147.92M6.15M-16.84M16.40M-69.23M-10.19M0.91M-11.74M14.13M53.55M16.07M29.75M7.20M
Interest Paid
6.82M6.33M6.33M
Income Taxes PaidTaxes Paid
0.13M0.14M0.20M0.43M0.23M0.16M1.49M0.50M0.01M0.22M0.91M

Mirum Pharmaceuticals Cash Flow Statement API

Pull Mirum Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MIRM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY